Skip to content

Detection of Ultrasound Contrast Signals in the Cerebral Circulation

Detection of Ultrasound Contrast Signals in the Cerebral Circulation During Stress Echocardiography

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00579241
Enrollment
0
Registered
2007-12-24
Start date
2006-04-27
Completion date
2009-12-12
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Vascular Disorders, Coronary Artery Disease

Brief summary

To Determine whether transcranial ultrasound can detect the presence of intravenously injected microbubbles used routinely for dobutamine stress echocardiography.

Detailed description

The purpose of this study is to determine whether the intravenous microbubbles used to improve border delineation during dobutamine stress echocardiographies (DSE) can be detected within the cerebral circulation.

Interventions

PROCEDUREUltrasound on Temporal Bone

All Patients undergoing dobutamine stress echocardiography have an intravenous line placed and a continuous infusion of a commercially available contrast agent administered. Prior to contrast infusion, baseline transcranial ultrasound images at 0.4 mechanical index using low mechanical index pulses and color Doppler will be performed and recorded. After this the contrast infusion will begin, and resting cardiac images will occur.

Sponsors

University of Nebraska
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* male or female age \>19 years of age * scheduled for a stress echocardiogram * negative urine pregnancy test within two hours of ultrasound contrast administration required for females of childbearing age unless post-menopausal or with evidence of surgical sterilization * be conscious and coherent, and able to communicate effectively with trial personnel

Exclusion criteria

* pregnant or lactation * life expectancy of less than 2 months or terminally ill * Known or suspected hypersensitivity to ultrasound contrast agent used for the study * complicated hemodynamic instability * Known left main disease

Design outcomes

Primary

MeasureTime frameDescription
Detect abnormalities in cerebral blood flowimmediateAll Patients undergoing dobutamine stress echocardiography have an intravenous line placed and a continuous infusion of a commercially available contrast agent administered. Prior to contrast infusion, baseline transcranial ultrasound images at 0.4 mechanical index using low mechanical index pulses and color Doppler will be performed and recorded. After this the contrast infusion will begin, and resting cardiac images will occur.

Secondary

MeasureTime frameDescription
if cerebral vascular disease is detected it would lead to further testing that may better identify abnormalities.within 30 minutesAll Patients undergoing dobutamine stress echocardiography have an intravenous line placed and a continuous infusion of a commercially available contrast agent administered. Prior to contrast infusion, baseline transcranial ultrasound images at 0.4 mechanical index using low mechanical index pulses and color Doppler will be performed and recorded. After this the contrast infusion will begin, and resting cardiac images will occur.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026